The goal of this study is to understand how exogenous kisspeptin affects metabolism by evaluating responses to an hyperglycemic clamp
Assignment: Each study subject will serve as their own control. The order of the visits will be randomized. Delivery of Interventions: Prior to the study visit, subjects will undergo a review of their medical history and screening laboratories. During the inpatient study, the subjects will Undergo a 16-hour kisspeptin infusion Undergo a hyperglycemic clamp
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Administration of a hyperglycemic clamp
Administration of kisspeptin-10 \* 16 hr
Administration of placebo \*16 hr
Massachusetts General Hospital
Boston, Massachusetts, United States
First Phase Insulin Secretion
Average Change in First Phase Insulin Secretion Between Kisspeptin and Placebo Arms
Time frame: 10 minutes
Second Phase Insulin Secretion
Average Change in Second Phase Insulin Secretion Between Kisspeptin and Placebo Arms
Time frame: 2 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.